Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3)

קרןNational Institutes of Health (NIH)
סוגResearch Grants
תאריך אחרון06/03/2019
פקולטהLife Sciences, Medicine, Social Sciences

The purpose of this grant is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain. The goal of the program is to accelerate the optimization and development of promising small molecule and biologic hits/leads towards clinical trials.


Funding:  UG3 $500,000 per year , UH3 $1,500,000 per year 

Duration: UG3 2 years, UH3 3 years


Research Authority due date: 27.11.18, 31.1.19

LOI (encouraged) due date: 4.12.18, 6.2.19


קבצים מצורפים
עדכון אחרוןעדכון אחרון: 06/11/2018
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive